Skip to content
10-Q

Quarterly Report

CUMBERLAND PHARMACEUTICALS INC CPIX

0001628280-25-039326

← back to feed
Filed
Aug 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 5, 2025 14.96M sh
Shares Diluted Q2 2025 · Jun 30, 2025 14.96M sh
Shares Diluted Q2 2025 · Jun 30, 2025 15.27M sh
Shares Diluted Q2 2025 · Jun 30, 2024 14.12M sh
Shares Diluted Q2 2025 · Jun 30, 2024 14.11M sh
Stock Repurchased Q2 2025 · Jun 30, 2025 $253.04K
Stock Repurchased Q2 2025 · Jun 30, 2024 $381.85K
Capex Q2 2025 · Jun 30, 2025 $74.12K
Capex Q2 2025 · Jun 30, 2024 $48.8K
Operating Cash Flow Q2 2025 · Jun 30, 2025 $4.74M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$2.99M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $16.09M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $17.96M
Stockholders Equity Q2 2025 · Jun 30, 2025 $27.99M
Stockholders Equity Q2 2025 · Dec 31, 2024 $22.85M
Current Liabilities Q2 2025 · Jun 30, 2025 $23.97M
Current Liabilities Q2 2025 · Dec 31, 2024 $31.62M
Total Liabilities Q2 2025 · Jun 30, 2025 $40.23M
Total Liabilities Q2 2025 · Dec 31, 2024 $53.04M
Current Assets Q2 2025 · Jun 30, 2025 $31.21M
Current Assets Q2 2025 · Dec 31, 2024 $36.45M
Total Assets Q2 2025 · Jun 30, 2025 $67.91M
Total Assets Q2 2025 · Dec 31, 2024 $75.58M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.05
Eps Diluted Q2 2025 · Jun 30, 2025 $0.03
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.08
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.21
Eps Basic Q2 2025 · Jun 30, 2025 −$0.05
Eps Basic Q2 2025 · Jun 30, 2025 $0.03
Eps Basic Q2 2025 · Jun 30, 2024 −$0.08
Eps Basic Q2 2025 · Jun 30, 2024 −$0.21
Sga Expense Q2 2025 · Jun 30, 2025 $2.87M
Sga Expense Q2 2025 · Jun 30, 2025 $5.34M
Sga Expense Q2 2025 · Jun 30, 2024 $2.76M
Sga Expense Q2 2025 · Jun 30, 2024 $5.13M
Rd Expense Q2 2025 · Jun 30, 2025 $1.47M
Rd Expense Q2 2025 · Jun 30, 2025 $2.76M
Rd Expense Q2 2025 · Jun 30, 2024 $1.06M
Rd Expense Q2 2025 · Jun 30, 2024 $2.22M
Net Income Q2 2025 · Jun 30, 2025 −$740.74K
Net Income Q2 2025 · Jun 30, 2025 $516.33K
Net Income Q2 2025 · Jun 30, 2024 −$1.09M
Net Income Q2 2025 · Jun 30, 2024 −$3.03M
Operating Income Q2 2025 · Jun 30, 2025 −$747.48K
Operating Income Q2 2025 · Jun 30, 2025 $544.47K
Operating Income Q2 2025 · Jun 30, 2024 −$1.03M
Operating Income Q2 2025 · Jun 30, 2024 −$2.9M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $2.01M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $3.44M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $1.71M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $3.29M
Revenue Q2 2025 · Jun 30, 2025 $10.84M
Revenue Q2 2025 · Jun 30, 2025 $22.55M
Revenue Q2 2025 · Jun 30, 2024 $9.85M
Revenue Q2 2025 · Jun 30, 2024 $18.35M